{"cmr":"uk-cm-kg/AIM/CRTX","since":null,"total":37,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-11-02","event_type":"early_warning","title":"Holding(s) in Company","rns_category":"Holding(s) in Company","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/holding-s-in-company/9854164","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"FOGIFsNajck2_QTEmrWO4hGdzCC4Zd-nxiEeQ-ac0iLe99z8mOto_BTsnDF9jaRmGLcCrcVOb29OT1bndNoFAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-10-27","event_type":"agm_record_date","title":"Result of AGM","rns_category":"Result of AGM","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/result-of-agm/9843981","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nHSk_IxKOCjaWfszAdz4Nz0OX24txk7JvrP327EuDVy5r_nPDl-dLEMq9KJFbLFr3d_2ESFCIanpXSk0KkOeDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-10-27","event_type":"agm_record_date","title":"AGM Statement","rns_category":"AGM Statement","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/agm-statement/9842298","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"BvCzY49_j1clWFWiP8oTTlIZOmZygZ1K-ngRYlPOP44V9fvXrbnAqTv-MaOwYTuq22ZHDF9ZJWTwrHKClz2hBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-10-15","event_type":"corporate_action","title":"Issue of Equity","rns_category":"Issue of Equity","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/issue-of-equity/9823580","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"dSn8-ZQGPLNs0Nh2pA_4az0uWSY1u7_KusHUpreBsyFcZ-LUj8X2yR73JXPUX9v2lnrJOXOcWHRPagL7caDwCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-10-02","event_type":"agm_record_date","title":"Notice of AGM","rns_category":"Notice of AGM","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/notice-of-agm/9803046","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"X4hBIkbklajTBGT-AJujlEQuHm7lENtKPe0TzFMKPGTlDuy0nIV2uMolShVPc6GZVQ_q9wc9L7oahB9UH2VvAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-08-20","event_type":"regulatory_announcement","title":"Commencement of Patient Recruitment","rns_category":"Commencement of Patient Recruitment","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/commencement-of-patient-recruitment/9732148","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZClnJ1UyBVSJVk1AcL_yY_PWgtXo5YohbRBa2g4nBiIl3gRdni_2zf3mbHC7kyb5qGMHu9fEi1kDFvp8CFXKBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-08-13","event_type":"regulatory_announcement","title":"Clinical Trial Update","rns_category":"Clinical Trial Update","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/clinical-trial-update-/9719016","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"gEg2rdCaGa6zjLHq-xNIFimBStk3JzHGHUdOBHaekzWLhRKAY1EXIR-xQZmxqY8RBKfxhiy5wnkqjtR6zeeTAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-07-29","event_type":"early_warning","title":"Holding(s) in Company","rns_category":"Holding(s) in Company","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/holding-s-in-company/9694407","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"VOUwVOXrHGGIadp8Zkfu3Pn-mgqUS-fZBhDZbVGnLgbL01H0i3aTKl9Ox2R_ZBiXStIE6b48znIplDpwcOfuBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-07-27","event_type":"regulatory_announcement","title":"Result of Shareholder Analysis","rns_category":"Result of Shareholder Analysis","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/result-of-shareholder-analysis/9687766","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"SZd-QqepaSz7h5SX8Mo5YWdYwNi_56JUc36ES09dyjoGBsYo-M2mako-i6W-du2rFvsSMc84-UhHsVMapWpIAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-07-02","event_type":"early_warning","title":"Holding(s) in Company","rns_category":"Holding(s) in Company","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/holding-s-in-company/9650479","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"uheZjqwsSguWrh4vW984g-a6NenJe5XXOk7KizgKc-Kr54DuJZ7f6mrFpEqL1Z7DmMjEzFXvv53DdkAcmt44BQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-06-30","event_type":"regulatory_announcement","title":"Grant of Options","rns_category":"Grant of Options","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/grant-of-options-/9645220","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DSszL_ghaUZlVDbuoxTAFy1LbS_ZGirVAbYPqoEJrr9UJiudlB1iYijn80RbeJzDto4NO2KqO1fED8-z_DjaDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-06-26","event_type":"financial_statement","title":"FINAL RESULTS","rns_category":"FINAL RESULTS","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/final-results/9637886","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Ev9Ne7OgPgLPxqsNHWsucrWndGsz5rsN2s1yoIcnpi5e3Tcw7dgCYgxtQbA-tjJNdkA4fN6vJQZVsxYxSODgCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-06-25","event_type":"regulatory_announcement","title":"Phase 2 Clinical Trial Progress Update","rns_category":"Phase 2 Clinical Trial Progress Update","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/phase-2-clinical-trial-progress-update-/9635384","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZZAKeE2AL-HKl36QHxd_kYg3aFg2kmGW53fVA8s0OCquNgHRtbkGiXuJKsNmYOZhtT8aAFB04yWFNCZHoCWJAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-06-22","event_type":"early_warning","title":"Holding(s) in Company","rns_category":"Holding(s) in Company","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/holding-s-in-company/9629604","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"bLUYEql6g-fLmGkwWDSRrBblDdG0J3vuBOIdyuDqAmjUI2Lixc6zim3O-sHLK2nvrzBhIyma34E4pzJkvy1qDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-06-16","event_type":"early_warning","title":"Holding(s) in Company","rns_category":"Holding(s) in Company","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/holding-s-in-company/9621628","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"uPKmLzCM_nd9SGeNhi5XSi4JI7OY2jX-4qgJFP3hjmkluRyRVZW0bTaE4G4vnhp50kHz31rg-hZRg-51dS8XAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-06-15","event_type":"agm_record_date","title":"Result of General Meeting","rns_category":"Result of General Meeting","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/result-of-general-meeting-/9618603","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NYgWBkI9T9kGiSVg-vmP1TNiNgPjy1CQIbMnhLxqozkpCM6fatQJv9KVPq6-E6DKV5TOLaaX6RhBeufOVWyJDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-06-04","event_type":"regulatory_announcement","title":"Significant Grant Award","rns_category":"Significant Grant Award","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/significant-grant-award/9600723","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"A1xl007P1-0aVkRDB-FzYSqP7lISXmQJV6y_s1CjMDBLgJNp70r5VvmohlQdh6O8hqJv2BqKUwnEGUhh1M5jAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-06-01","event_type":"regulatory_announcement","title":"Grant Award","rns_category":"Grant Award","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/grant-award/9593417","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"SNNUGalMvlsdE148b57p_yfd8W-n-pNtRjppbzkBDFEvMr3-mJQCltQHViUf7J7AG1cCzaf45-JBu8wE6IqUCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-05-28","event_type":"regulatory_announcement","title":"Result of Retail Offer","rns_category":"Result of Retail Offer","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/result-of-retail-offer/9590417","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"7ebWVVxlZy0xWZDZwoLCF-yxKz1kK1knkiHRybn2vnenrzjF_v_P8dGKNbl_i_k5axYkmfrpYSY-pEcvVTTJCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-05-27","event_type":"agm_record_date","title":"Notice of General Meeting","rns_category":"Notice of General Meeting","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/notice-of-general-meeting/9587499","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DB9OhdnquzWAookXBcI9ELi0V3KwfqWp-VTTuexKfWVpW48AAhhdGc9sLPo-qu9GRoI8m1wUkHh_8DD3tCpDDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-05-26","event_type":"corporate_action","title":"Placing of £2.5 million","rns_category":"Placing of £2.5 million","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/placing-of-2-5-million-/9583883","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nxClS6Yx6OYYHXf79V-JN3ow3pa5HODW2IlBi4iPk41LNh2W1Tnx-dKEEDm2I-Wmdfks1p-duxziIpU-KHxdAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-05-26","event_type":"regulatory_announcement","title":"Retail Offer to raise up to £100,000","rns_category":"Retail Offer to raise up to £100,000","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/retail-offer-to-raise-up-to-100-000-/9584267","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"3v7QSX14znKPtdl5XHQHOTGDwBUifrAONp8lEX3in_cX2EI_0wg7EyJy3TIKjjunN1qu0P2MWhQ5gGw96MYiCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-05-14","event_type":"ch_officer_change","title":"termination person director overseas company with name termination date — Nermeen Yunus Varawalla; 2026-04-02","ch_filing_type":"officers","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/FC042176/filing-history/MzUyMDQ4MTU1MWFkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form OSTM01; category officers","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Yrq44bNwTJex0HL6p3uTyG8Z6ftSqBcrjt66o9p3MceCOgufoyBjowpCwm8mAY1VgzMUVm41EXuz6xNBv2RUCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-04-21","event_type":"regulatory_announcement","title":"Positive Preclinical Data for Docetaxel ChemoSeed","rns_category":"Positive Preclinical Data for Docetaxel ChemoSeed","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/positive-preclinical-data-for-docetaxel-chemoseed/9529231","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"y9SHX26bQ-lHnphDY9isKu84Jk6DdarUakqal48mWeo9rcdmQj_oJwLC8ZNZ2mkcVkbaeFV_Ospa9z9DPs1_CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-04-02","event_type":"regulatory_announcement","title":"Board Changes","rns_category":"Board Changes","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/board-changes-/9504435","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nJRI9U0frLzQlZBwdc5c5Ggzbm-G2Fsf_DHlYeg7N45ILV4IYDtp7b3NXGXSP82Pk70V7uYGbXZzOY4-8x1OBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-03-25","event_type":"regulatory_announcement","title":"Phase 2 Clinical Trial Progress Update","rns_category":"Phase 2 Clinical Trial Progress Update","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/phase-2-clinical-trial-progress-update-/9490199","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"F2HhwRPXfT549jtnNYD27DQrq92nzX60mfmt4H4Z-eV9gTvzMz0qhAH-vSUm8R7OYLtD6dKuaoBEsIbGxHTDBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-03-17","event_type":"regulatory_announcement","title":"Awarding of Orphan Drug Designation by the FDA","rns_category":"Awarding of Orphan Drug Designation by the FDA","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/awarding-of-orphan-drug-designation-by-the-fda/9477015","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"wBTJoJkxXqkfMUaNhaUPtoEOioLvlj2-HZ2p2AoBZTSAvDByqmsBdK-eY_asUVlJ4-GN4u2ZVDQRHrREOLjXBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-01-20","event_type":"regulatory_announcement","title":"Japanese Patent Grant","rns_category":"Japanese Patent Grant","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/japanese-patent-grant/9367760","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"HgjREAzLfC0nzC4R--XMRXIvRZsiVlf4kdF9iRwWHtI_7IDjJkLYqKqEbZeLL3WSqlFf49T7gT5o_4OKcP7eDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2026-01-09","event_type":"regulatory_announcement","title":"Results of Shareholder Analysis","rns_category":"Results of Shareholder Analysis","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/results-of-shareholder-analysis-/9342889","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"STa_USiO-l-rU_KeU0Ewvt6-fuiLQARR6ROnFHax3nzQGQjpyepCKeydhlFbkVsjzgeRQBfq_rTCnFJIbxeFCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2025-12-15","event_type":"regulatory_announcement","title":"Result of Retail Offer","rns_category":"Result of Retail Offer","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/result-of-retail-offer/9297795","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Ks_p7yE60iH96xDyOw6rY6UGvD0poqJhmn6kCxtOIMpD5TLC2K5sYr9iXCZRRx4RNAsFRAjC68bgpOwKT9RSBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2025-12-10","event_type":"corporate_action","title":"Placing of £1,000,000","rns_category":"Placing of £1,000,000","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/placing-of-1-000-000/9286613","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Hly2lDJ8sHVfrjITVbPxTsAIUXXOye1zQsaXSZ4RFY1XWeWI14TVC44ZCgE2WLckH0gE6AfoVuxrOcoJszz3Bw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2025-12-10","event_type":"regulatory_announcement","title":"Retail Offer","rns_category":"Retail Offer","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/retail-offer/9287250","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Q9J0iI3ShZmp6fqNste8EMWxH-fqkrJ4kpHfpTK_ZE5iNJ5qrAAJYGoyckZ07cvL5xrwpwJN1ZpJn-BEDIpRAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2025-11-27","event_type":"early_warning","title":"Holding(s) in Company","rns_category":"Holding(s) in Company","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/holding-s-in-company/9260013","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"bG8Lq6PU-NI5EFpvwUiRheXcoRXfeEgDXjbqXf3qay7mRKtpJ0hDfHhRttIHlyANpHr8X7JFxQh60XRNh3glDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2025-10-30","event_type":"regulatory_announcement","title":"US Orphan Drug Designation Application","rns_category":"US Orphan Drug Designation Application","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/us-orphan-drug-designation-application/9202797","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"b51uS0yrDYrUn-l8MHMklanREsHIqXcwuEvv_hn8wfuUWoHxpKSrUD_IPFlFOoJo5szZDSoX2vlPDIN1dFqtDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2025-10-14","event_type":"regulatory_announcement","title":"Positive Preclinical Data in Prostate Cancer","rns_category":"Positive Preclinical Data in Prostate Cancer","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/positive-preclinical-data-in-prostate-cancer/9168716","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"K-r8c_cLPKXHXmZ3zigEwJBOtT2gLgK0kSk5qlWbgqxylQPnMLy-l7RNXLZlkqLwVKMLr1XAAwyLhsWCu3alCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2025-09-15","event_type":"financial_statement","title":"Half Year Report","rns_category":"Half Year Report","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/half-year-report/9106943","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"K4URxjECDxJ-cpYiLMqVXjv9WDyfxPQp8KMMrHjpFSjGXClAg3FuUSBt7IXjTzY2xWJSoQfBP5Z_7s4hgGroCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/CRTX","date":"2025-09-12","event_type":"financial_statement","title":"Notice of Interim Results and IMC Presentation","rns_category":"Notice of Interim Results and IMC Presentation","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/crism-therapeutics-corporation-ord-npv--crtx/notice-of-interim-results-and-imc-presentation-/9103216","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"WcXqw6ZoZ2Pc1_BkMD8X3_jUj2u2pzyO3dYep_J43jY1MZgaTvGTgjJJYvtj-Lnz51ocNhhn9SvrIuh9ipCKDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}